PHARMA NORD EXPORT ApS: Financial statements 2025
CVR: 70996510
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. That is an increase of 18.3% compared with the year before. Equity in the 2025 report amounted to DKK 46,928,000. The solvency ratio was 60.4%. The company had 66 employees in the financial year.
- Gross Profit
- DKK 1,575,000
- Profit/Loss
- DKK 11,516,000
- Equity
- DKK 46,928,000
- Total Assets
- DKK 77,700,000
- Employees
- 66
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.6 mio. | 11.5 mio. | 46.9 mio. | 66 |
| 2024 | - | 1.3 mio. | 6.9 mio. | 44.2 mio. | 77 |
| 2023 | - | 1.4 mio. | 6.3 mio. | 37.4 mio. | 65 |
| 2022 | - | 1.6 mio. | 2.1 mio. | 46 mio. | 63 |
| 2021 | - | 1.7 mio. | 3.2 mio. | 43.9 mio. | 49 |
Official annual report
How creditworthy is PHARMA NORD EXPORT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMA NORD EXPORT ApS has published its annual report for 2024. Gross profit came to DKK 1,331,908, and the net result was DKK 6,889,205.
As of May 30, 2025, Sven Moesgaard has left the board of directors of PHARMA NORD EXPORT ApS.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named TRAUDE SCHNEIDER ASTROFAKTA-DANMARK ApS. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.